Hypertrophic cardiomyopathy with coronary artery disease: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Concomitant Coronary Disease== | ==Concomitant Coronary Disease== | ||
===2011 ACCF/AHA Guideline Recommendations: Detection of Concomitant Coronary Disease(DO NOT EDIT)=== | ===2011 ACCF/AHA Guideline Recommendations: Detection of Concomitant Coronary Disease(DO NOT EDIT)=== | ||
{{cquote| | |||
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]==== | |||
====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm)==== | |||
====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]==== | |||
}} | |||
==References== | ==References== | ||
Revision as of 20:35, 1 October 2012
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy with coronary artery disease On the Web |
|
FDA on Hypertrophic cardiomyopathy with coronary artery disease |
|
CDC on Hypertrophic cardiomyopathy with coronary artery disease |
|
Hypertrophic cardiomyopathy with coronary artery disease in the news |
|
Blogs on Hypertrophic cardiomyopathy with coronary artery disease |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy with coronary artery disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Concomitant Coronary Disease
2011 ACCF/AHA Guideline Recommendations: Detection of Concomitant Coronary Disease(DO NOT EDIT)
| “ |
Class I=Class III (Harm)Class IIa |
” |